Filing Details

Accession Number:
0000950170-23-041288
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-10 16:04:17
Reporting Period:
2023-08-08
Accepted Time:
2023-08-10 16:04:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX Pharmaceutical Preparations (2834) 270605902
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777631 K. Stephen Brannan C/O Karuna Therapeutics, Inc.
99 High Street, 26Th Floor
Boston MA 02110
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-08 2,500 $5.45 26,150 No 4 M Direct
Common Stock Acquisiton 2023-08-08 5,000 $131.64 31,150 No 4 M Direct
Common Stock Disposition 2023-08-08 2,395 $179.53 28,755 No 4 S Direct
Common Stock Disposition 2023-08-08 1,355 $180.93 27,400 No 4 S Direct
Common Stock Disposition 2023-08-08 1,250 $181.50 26,150 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2023-08-08 2,500 $0.00 2,500 $5.45
Common Stock Option (right to buy) Disposition 2023-08-08 5,000 $0.00 5,000 $131.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,177 2027-06-01 No 4 M Direct
46,350 2031-02-22 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.22 to $180.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (4) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.30 to $181.24, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.33 to $181.99, inclusive.
  5. This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2017, with additional vesting as to 12.5% of the shares underlying the option award at the end of each six month period thereafter.
  6. This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of February 23, 2021, with additional vesting as to 6.25% of the shares underlying the option award at the end of each three month period thereafter.